Literature DB >> 3553799

The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis.

J Convit, M Ulrich, N Aranzazu, P L Castellanos, M E Pinardi, O Reyes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3553799     DOI： 10.5935/0305-7518.19860080

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  7 in total

1.  Serological monitoring of previously treated lepromatous patients during a course of multiple immunotherapy treatments with heat-killed Mycobacterium leprae and BCG.

Authors:  J T Douglas; D S Hirsch; T T Fajardo; L S Guido; P R Klatser
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.

Authors:  G Kaplan; G Sheftel; C K Job; N K Mathur; I Nath; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients.

Authors:  M C Sasiain; S de la Barrera; F Minnucci; R Valdez; M M de Elizalde de Bracco; L M Baliña
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization.

Authors:  N Rodríguez; B Guzman; A Rodas; H Takiff; B R Bloom; J Convit
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

5.  Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.

Authors:  J Convit; H Montesinos; H Oviedo; G Romero; B Maccarone; E Essenfeld; A Convit; L E Palacios
Journal:  Clin Transl Oncol       Date:  2015-06-16       Impact factor: 3.405

6.  Toxicity evaluation of ConvitVax breast cancer immunotherapy.

Authors:  María A Duarte C; Jeismar M Carballo O; Yetsenia M De Gouveia; Angie García; Diana Ruiz; Teresa Gledhill; Eglys González-Marcano; Ana F Convit
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

7.  Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response.

Authors:  María José Godoy-Calderón; Víctor Salazar; Eglys González-Marcano; Ana Federica Convit
Journal:  Oncotarget       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.